Literature DB >> 17543991

Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

Claire Paquet1, Michèle Boissonnot, Florent Roger, Paul Dighiero, Roger Gil, Jacques Hugon.   

Abstract

In Alzheimer's disease (AD), brain lesions are marked by severe neuronal loss and retinal degeneration was previously mentioned in affected patients. Mild cognitive impairment (MCI) is a clinical syndrome that could be an early phase of AD. In this study, using optical coherence tomography (OCT), the retinal nerve fiber layer (RNFL) thickness was assessed in patients with mild AD, moderate to severe AD, amnestic MCI and control subjects. The results show that RNFL thickness is statistically reduced in patients with MCI, mild AD or moderate to severe AD compared to controls. In addition, no statistical difference was found between the results in MCI patients and mild AD patients. The RNFL seems to be involved early during the course of amnestic MCI and OCT tests could be carried out in patients with cognitive troubles.

Entities:  

Mesh:

Year:  2007        PMID: 17543991     DOI: 10.1016/j.neulet.2007.02.090

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  145 in total

1.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xue-Fei He; Yi-Ting Liu; Cheng Peng; Fan Zhang; Shi Zhuang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 3.  Optical coherence tomography: a window into the mechanisms of multiple sclerosis.

Authors:  Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary Cutter; Laura J Balcer
Journal:  Nat Clin Pract Neurol       Date:  2008-12

4.  Reduction in retinal nerve fiber layer thickness in young adults with autism spectrum disorders.

Authors:  Leonardo Emberti Gialloreti; Matteo Pardini; Francesca Benassi; Sara Marciano; Mario Amore; Maria Giulia Mutolo; Maria Cristina Porfirio; Paolo Curatolo
Journal:  J Autism Dev Disord       Date:  2014-04

5.  Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.

Authors:  Sylvia E Perez; Stephen Lumayag; Beatrix Kovacs; Elliott J Mufson; Shunbin Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

Review 6.  Protein misfolding and retinal degeneration.

Authors:  Radouil Tzekov; Linda Stein; Shalesh Kaushal
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

7.  Thinner Retinal Nerve Fiber Layer in Very Preterm Versus Term Infants and Relationship to Brain Anatomy and Neurodevelopment.

Authors:  Adam L Rothman; Monica B Sevilla; Shwetha Mangalesh; Kathryn E Gustafson; Laura Edwards; C Michael Cotten; Joshua S Shimony; Carolyn E Pizoli; Mays A El-Dairi; Sharon F Freedman; Cynthia A Toth
Journal:  Am J Ophthalmol       Date:  2015-09-18       Impact factor: 5.258

8.  Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.

Authors:  İpek Sönmez; Ferdi Köşger; Ümit Aykan
Journal:  Noro Psikiyatr Ars       Date:  2017-03       Impact factor: 1.339

9.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

Authors:  Allison Ning; Jing Cui; Eleanor To; Karen Hsiao Ashe; Joanne Matsubara
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

10.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.